Adial Pharmaceuticals, Inc. Amortization of Debt Issuance Costs and Discounts
Adial Pharmaceuticals, Inc. (ADIL) reported Amortization of Debt Issuance Costs and Discounts of $109.93 thousand for the 3-month period ending 2018-09-30, per its 10-Q filed 2019-11-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:AmortizationOfFinancingCostsAndDiscounts · last filed 2019-11-14
- Adial Pharmaceuticals, Inc. amortization of debt issuance costs and discounts for the quarter ending 2018-09-30 was $109.93K.
| Period end | Amortization of Debt Issuance Costs and Discounts 3 month | Amortization of Debt Issuance Costs and Discounts 6 month | Amortization of Debt Issuance Costs and Discounts 9 month |
|---|---|---|---|
| 2018-09-30 | $109.93K 10-Q · filed 2019-11-14 | $138.60K 10-Q · filed 2019-11-14 | |
| 2018-06-30 | $28.68K 10-Q · filed 2019-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |